Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenue

Key PointsJohnson & Johnson currently exhibits a stronger overall revenue profile than Pfizer by maintaining consistently higher absolute sales volume across every reported period.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Tuesday 17 November →